Literature DB >> 11416871

Changes in arterial oxygen tension when weaning neonates from inhaled nitric oxide.

G M Sokol1, N S Fineberg, L L Wright, R A Ehrenkranz.   

Abstract

We set out to evaluate changes in arterial oxygen tension (PaO(2)) when weaning neonates from inhaled nitric oxide (INO). We reviewed the records of 505 prospectively collected INO weaning attempts on 84 neonates with hypoxic respiratory failure. PaO(2) values before and 30 min after weaning attempts were recorded. Relationships between change in PaO(2) and decreases in INO concentrations were investigated using regression analysis and ANOVA. PaO(2) decreased (-18.7 +/- 1.8 torr; P < 0.001); when weaning INO. A stepwise decline in PaO(2) was observed weaning INO from 40 ppm. The greatest decline occurred when INO was discontinued (-42.1 +/- 4.1 torr). Forward stepwise multiple regression using variables with significant relationships to the decline in PaO(2) identified the specific dose reduction 7(P < 0.001), the prewean PaO(2) (P < 0.001), and surfactant therapy (P = 0.018) as the variables best describing the change in PaO(2)(P = 0.004, r = 0.51). In conclusion, a graded decline in PaO(2) occurs when reducing INO. INO should be weaned to less than 1 ppm before discontinuing its use. Prior surfactant treatment appears to enhance the oxygenation reserve when weaning INO. Copyright 2001 Wiley-Liss,Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11416871     DOI: 10.1002/ppul.1083

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  10 in total

Review 1.  Inhaled nitric oxide therapy for pulmonary disorders of the term and preterm infant.

Authors:  Gregory M Sokol; Girija G Konduri; Krisa P Van Meurs
Journal:  Semin Perinatol       Date:  2016-10       Impact factor: 3.300

Review 2.  Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; D Willson; R H Notter
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

3.  Persistent Pulmonary Hypertension of the Newborn.

Authors:  Satyan Lakshminrusimha; Martin Keszler
Journal:  Neoreviews       Date:  2015-12

4.  Update on PPHN: mechanisms and treatment.

Authors:  Jayasree Nair; Satyan Lakshminrusimha
Journal:  Semin Perinatol       Date:  2014-03       Impact factor: 3.300

Review 5.  Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; Gloria S Pryhuber; Patricia R Chess; Bruce A Davidson; Paul R Knight; Robert H Notter
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 6.  Inhaled nitric oxide therapy in neonates and children: reaching a European consensus.

Authors:  Duncan J Macrae; David Field; Jean-Christophe Mercier; Jens Møller; Tom Stiris; Paolo Biban; Paul Cornick; Allan Goldman; Sylvia Göthberg; Lars E Gustafsson; Jürg Hammer; Per-Arne Lönnqvist; Manuel Sanchez-Luna; Gunnar Sedin; Nim Subhedar
Journal:  Intensive Care Med       Date:  2004-01-13       Impact factor: 17.440

Review 7.  Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn.

Authors:  G Ganesh Konduri; U Olivia Kim
Journal:  Pediatr Clin North Am       Date:  2009-06       Impact factor: 3.278

8.  Pulmonary vasodilator therapy in persistent pulmonary hypertension of the newborn.

Authors:  T J Kulik; J E Lock
Journal:  Clin Perinatol       Date:  1984-10       Impact factor: 3.430

9.  Persistent pulmonary hypertension of the newborn.

Authors:  Vinay Sharma; Sara Berkelhamer; Satyan Lakshminrusimha
Journal:  Matern Health Neonatol Perinatol       Date:  2015-06-03

Review 10.  Pathophysiology and Management of Persistent Pulmonary Hypertension of the Newborn.

Authors:  Yogen Singh; Satyan Lakshminrusimha
Journal:  Clin Perinatol       Date:  2021-08       Impact factor: 2.642

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.